CLS Holdings USA, Inc. Note Agreements

47 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Convertible Promissory Note dated January 10, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $50,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Amended Convertible Promissory Note made by CLS Holdings, Inc. in favor of FK Legacy Trust
Note Agreements
CLS Holdings USA, Inc.
2024
Convertible Promissory Note to FK Legacy Trust ($2,600,000)
Note Agreements
CLS Holdings USA, Inc.
2024
Secured Promissory Note dated February 22, 2024, made by the Company in favor of Ian Whitmore
Note Agreements
CLS Holdings USA, Inc.
2024
Secured Promissory Note dated February 22, 2024, made by the Company in favor of LEM Investments LLC
Note Agreements
CLS Holdings USA, Inc.
2024
Secured Promissory Note dated February 22, 2024, made by the Company in favor of Patrick Haldan
Note Agreements
CLS Holdings USA, Inc.
2024
Secured Promissory Note dated February 22, 2024, made by the Company in favor of FK Legacy Trust
Note Agreements
CLS Holdings USA, Inc.
2024
Form of Secured Promissory Note
Note Agreements
CLS Holdings USA, Inc.
2024
Secured Promissory Note, dated June 11, 2021, issued by In Good Health Inc. in favor of CLS Holdings USA, Inc. in the original principal amount of $3,000,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2021
First Amendment to Secured Promissory Note and Security Agreement and Termination of Membership Interest Purchase Agreement, dated August 26, 2019, by and among CannAssist and CLS...
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2019
Secured Promissory Note, dated January 29, 2019, issued by CannAssist, LLC in favor of CLS Holdings USA, Inc
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2019
Secured Promissory Note, dated October 31, 2018, issued by In Good Health, Inc. in favor of CLS Holdings USA, Inc
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Convertible Promissory Note dated August 6, 2018 in favor of Newcan Investment Partners LLC in the original principal amount of $75,000.00
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
6% Secured Promissory Note of CLS Holdings USA, Inc. in favor of Serenity Wellness Enterprises, LLC, as nominee, in the aggregate principal amount of $4,000,000 dated June 27, 2018
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2018
Convertible Promissory Note dated April 6, 2018 in favor of Jeffrey Binder in the original principal amount of $37,500.00
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Convertible Promissory Note dated February 20, 2018 in the original principal amount of $31,250 made by CLS Holdings USA, Inc. in favor of David Lamadrid
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note dated February 12, 2018 in the original principal amount of $55,000 made by CLS Holdings USA, Inc. in favor of Efrat Investments LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note dated February 5, 2018 in the original principal amount of $550,000 made by CLS Holdings USA, Inc. in favor of Darling Capital LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2018
Omnibus Amendment to Convertible Notes dated January 10, 2018, effective December 1, 2017, among CLS Holdings USA, Inc., Jeffrey I. Binder and Newcan Investment Partners, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Convertible Promissory Note dated January 5, 2018 in favor of Jeffrey Binder in the original principal amount of $165,360.19
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Convertible Promissory Note dated January 5, 2018 in favor of Newcan Investment Partners LLC in the original principal amount of $115,000.00
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2018
Senior Convertible Promissory Note dated November 15, 2017 in the original principal amount of $363,000 made by CLS Holdings USA, Inc. in favor of FirstFire Global Opportunities...
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NY
2017
Convertible Promissory Note dated October 9, 2017 in favor of Jeffrey Binder in the original principal amount of $39,520.56
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated October 9, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $29,999.50
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated August 23, 2017 in favor of Jeffrey Binder in the original principal amount of $72,767
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated August 23, 2017 in favor of Jeffrey Binder in the original principal amount of $115,050
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated August 23, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $70,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated August 23, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $621,658
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Amendment #5 to Convertible Promissory Note Issued on March 18, 2016, effective July 15, 2017, by and between CLS Holdings USA, Inc. and Old Main Capital, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Amendment #4 to Convertible Promissory Note Issued on March 18, 2016, effective June 30, 2017, by and between CLS Holdings USA, Inc. and Old Main Capital, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated March 31, 2017 in favor of Jeffrey Binder in the original principal amount of $159,500
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated March 31, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $120,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Amendment #3 to the Convertible Promissory Notes Issued on March 18, April 22 and May 27, 2016, dated March 27, 2017, by and between CLS Holdings USA, Inc. and Old Main Capital,...
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Convertible Promissory Note dated January 10, 2017 in favor of Newcan Investment Partners LLC in the original principal amount of $410,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2017
Amendment #2 to the Convertible Promissory Notes Issued on March 18, April 22 and May 27, 2016, dated November 28, 2016, by and between CLS Holdings USA, Inc. and Old Main...
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated August 3, 2016, in favor of CLS CO 2016, LLC
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated January 12, 2016, in favor of Jeffrey Binder
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated January 12, 2016 in favor of Frank Koretsky
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated July 20, 2016 in favor of Jeffrey Binder in the original principal amount of $262,750
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016
Convertible Promissory Note dated July 20, 2016 in favor of Frank Koretsky in the original principal amount of $210,000
Note Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2016